Clinical Research Details

Clinical Research

GS-US-445-4189- A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects with Active Sjogren’s Syndrome

Open Enrollment

Contact Name: Sarah Walters
Contact Phone: (904) 633-0071
Contact Email:


Principal Investigator
Gurjit S. Kaeley, M.D.